Publications
42
Citations
664
Est. group size
~2
Recurring co-author estimate
Active years
8
Publishing since 2019
This research record centers on clinical trials evaluating COVID-19 vaccines, particularly the COVAIL trial studying antibody responses to bivalent and monovalent SARS-CoV-2 variant boosters, along with related work on RSV vaccination and infant immunization. The record also includes a more scattered set of publications on topics such as orthodontics, hospital infection control practices, and nursing workforce measurement tools, suggesting contributions across multiple collaborative clinical studies rather than a single focused lab. Prospective students should note that the bibliographic data suggests this name may be associated with several distinct research efforts rather than one continuous research program.
Publication output rose sharply in 2020, remained moderate through 2022-2023, then dropped notably in 2024-2025 before an increase projected for 2026, indicating an uneven rather than steadily growing pattern.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adults
Vaccine · 2026
- 225. The Immunology and Safety of Maternal RSV Vaccination, Infant Nirsevimab Immunization, or Both Products- Interim Analysis of a Randomized Clinical Trial
Open Forum Infectious Diseases · 2026
- The neutralizing antibody titer correlate of COVID-19 risk in the COVID-19 variant immunologic landscape (COVAIL) trial was not modified by SARS-CoV-2 amino acid sequence distances
Vaccine · 2026
- Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boost
Nature Communications · 2025
- Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL Trial
Clinical Infectious Diseases · 2024
- Comparison of bivalent and monovalent SARS-CoV-2 variant vaccines: the phase 2 randomized open-label COVAIL trial
Nature Medicine · 2023
- Immunogenicity of the BA.1 and BA.4/BA.5 Severe Acute Respiratory Syndrome Coronavirus 2 Bivalent Boosts: Preliminary Results From the COVAIL Randomized Clinical Trial
Clinical Infectious Diseases · 2023
- Clinicians’ perceptions on implementation strategies used to facilitate ABCDEF bundle adoption: A multicenter survey
Heart & Lung · 2023
- Rhinologist Use of Antibiotics With Nasal Packing for Epistaxis
American Journal of Rhinology and Allergy · 2023
- Immunogenicity of a 2-Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
The Journal of Infectious Diseases · 2023
- Bivalent and Monovalent SARS-CoV-2 Variant Vaccine Boosters Improve coverage of the known Antigenic Landscape: Results of the COVID-19 Variant Immunologic Landscape (COVAIL) Trial
Research Square · 2023
- Immunogenicity of the BA.1 and BA.4/BA.5 SARS-CoV-2 Bivalent Boosts: Preliminary Results from the COVAIL Randomized Clinical Trial
medRxiv · 2023
- Immunogenicity of a Two Dose Regimen of Moderna mRNA Beta/Omicron BA.1 Bivalent Variant Vaccine Boost in a Randomized Clinical Trial
medRxiv · 2023
- Associations among infection prevention professionals' mental/physical health, lifestyle behaviors, shift length, race, and workplace wellness support during COVID-19
American Journal of Infection Control · 2022
- Psychometric properties of the Organizational Culture and Readiness Scale for System‐Wide Integration of Evidence‐Based Practice
Worldviews on Evidence-Based Nursing · 2022
- Worldviews on Evidence-Based Nursing×3
- Progress in Orthodontics×2
- European Journal of Orthodontics×2
- Clinical Infectious Diseases×2
- Vaccine×2
- Jingyou Yu
Medicine · The Ohio State University
- Hadi M. Yassine
Medicine · Indiana University
- Cong Zeng
Medicine · The Ohio State University
- Jaffar A. Al‐Tawfiq
Medicine · Indiana University
- John P. Evans
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile